ZC3H7B-BCOR High-Grade Endometrial Stromal Sarcoma with a Mucoid Grossly Feature: A Case Report and Literature Review.
Wenxue ZhiXingzheng ZhengYulan JinPublished in: International journal of women's health (2022)
We report on a 50-year-old postmenopausal woman who presented with abnormal uterine bleeding and pelvic pain due to a uterine solid mass grew from the uterine fundus to the cervix and with so far undescribed obviously gelatinous grossly change, which was suspected of myxoid leiomyosarcoma in intraoperative diagnosis. Morphologically, the tumor cells displayed haphazard fascicles of uniform mild-to-moderate heteromorphic spindle cell component with significant and abundant myxoid stroma, forming signet ring cells and microcysts. Immunohistochemically, the tumour cells were diffusely positivefor CD10 and cyclin D1 and negative for Desmin and SMA, but the expression of BCOR staining was not present. The FISH study showed a positive BCOR gene break probe, and the RNA sequencing revealed an identified reciprocal fusion gene ZC3H7B-BCOR. The case was finally diagnosed as ZC3H7B-BCOR high-grade endometrial stromal sarcoma. Tumor recurrence occurred rapidly on the pelvic peritoneal and vaginal 2 months after resection. In conclusion, these findings further support ZC3H7B-BCOR HGESS has a poor prognosis and molecular testing of uterine mesenchymal tumors with myxoid matrix and unusual grossly presentation is recommended to avoid misdiagnosis.
Keyphrases
- poor prognosis
- high grade
- clear cell
- induced apoptosis
- cell cycle arrest
- single cell
- bone marrow
- long non coding rna
- low grade
- cell death
- stem cells
- genome wide
- rectal cancer
- endometrial cancer
- chronic pain
- endoplasmic reticulum stress
- gene expression
- copy number
- mesenchymal stem cells
- patients undergoing
- deep learning
- transcription factor
- atrial fibrillation
- quantum dots
- binding protein
- spinal cord
- preterm birth
- living cells
- neural network